| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -9.90M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, BDTX returned -24.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -9.1% |
| 1 year | -24.3% |
| 5 years | -78.1% |
| All-time high | $42.16 (Jun 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in BDTX would be worth today ›No. Black Diamond Therapeutics, Inc. has not paid a dividend in the past 12 months.
Black Diamond Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol BDTX.
Black Diamond Therapeutics, Inc. is part of the Healthcare sector.
Black Diamond Therapeutics, Inc. has a market cap of 126.64M USD, based on the latest quote.
Black Diamond Therapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
